NCT06462872View on ClinicalTrials.gov

To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

February 27, 2025

Study Completion Date

February 27, 2025

Conditions

Critically Ill Cirrhotics

Interventions

OTHER

observational study

It is an observational study

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT06462872 - To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics | Biotech Hunter | Biotech Hunter